Exhibit 99.1
[Letterhead of Sigma-Aldrich]
| | |
| From: David Harvey, Chairman, President and CEO | | For questions contact: |
| | | Kirk A. Richter, Treasurer |
| | | (314) 286-8004 |
FOR IMMEDIATE RELEASE
May 3, 2005
SIGMA-ALDRICH DIRECTORS ELECTED AND QUARTERLY DIVIDEND DECLARED
At the annual shareholders meeting held today in St. Louis, the following directors were re-elected: Nina V. Fedoroff, David R. Harvey, W. Lee McCollum, William C. O’Neil, Jr., J. Pedro Reinhard, D. Dean Spatz and Barrett A. Toan. Timothy R. G. Sear, Chairman of Alcon, Inc., was elected to his first term as a Director. Jerome W. Sandweiss retired as a Director after serving for 30 years. Shareholders also ratified the appointment of KPMG LLP as the Company’s independent registered public accountant for 2005.
At the Board of Directors meeting held today, the Directors declared a quarterly cash dividend of $.19 per share. The dividend is payable on June 15, 2005 to shareholders of record on June 1, 2005.
About Sigma-Aldrich: Sigma-Aldrich is a leadingLife Science andHigh Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and chemical manufacturing. We have customers in life science companies, university and government institutions, hospitals and in industry. Over one million scientists and technologists use our products. Sigma-Aldrich operates in 34 countries and has over 6,000 employees providing excellent service worldwide. We are committed to the success of our Customers, Employees and Shareholders through leadership inLife Science,High Technology andService. For more information about Sigma-Aldrich, please visit our award-winning web site atwww.sigma-aldrich.com
